MedTrace Logo

Measuring Cortisol Levels in Persons With Parkinson's (PD)

NCT02727270 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 131

Last updated 2023-12-22

No results posted yet for this study

Summary

The objective of this study is to evaluate the cortisol awakening response with persons with Parkinsons Disease (PD), Huntingtons Disease (HD), and controls. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD, HD, and controls.

Conditions

  • Parkinson Disease
  • Huntington Disease

Interventions

OTHER

No Intervention - Observational Study

No Intervention - Observational Study

Sponsors & Collaborators

  • Portland VA Medical Center

    collaborator FED

  • Oregon Clinical and Translational Research Institute

    collaborator OTHER

  • Huntington's Disease Society of America

    collaborator OTHER

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Amie L Hiller, MD · Oregon Health and Science University

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2023-11-16
Completion
2023-11-16

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02727270 on ClinicalTrials.gov